FDA: Guillain-Barre Possible Risk With Pfizer’s RSV Vaccine

March 16, 2023

https://www.cnbc.com/2023/02/24/fda-says-guillain-barre-syndrome-is-possible-risk-of-pfizer-rsv-vaccine.html

FDA says Guillain-Barre syndrome is possible risk of Pfizer’s RSV vaccine for older adults

Spencer Kimball@SPENCEKIMBALL
KEY POINTS
  • Two people in their 60s who received Pfizer’s RSV shot were diagnosed with Guillain-Barre syndrome, out of about 20,000 vaccine recipients.
  • The FDA sees a potential risk and has asked Pfizer to conduct a safety study on Guillain-Barre after a potential approval, which the company said it would do.
  • There was also a possible case of Guillain-Barre syndrome in GSK’s trials, but the company said there was insufficient evidence to confirm a diagnosis.
  • The FDA and the study investigator consider the GSK case to be related to the vaccine.

_______________

**Comment**

I assure you, if the FDA ever concedes anything, the problem in reality is far, far worse as the agency is riddled with conflicts of interest.  A perfect example is the VAERS data base which only captures 1% of vaccine injury and death:  https://madisonarealymesupportgroup.com/2020/12/21/warning-3150-injuries-in-1st-week-of-covid-vaccines-among-american-healthcare-workers-pregnant-women-included/

Category:

Activism, vaccines

Comments Off on FDA: Guillain-Barre Possible Risk With Pfizer’s RSV Vaccine

%d bloggers like this: